Tags: Coronavirus | coronavirus | cancer | screening | diagnosis

COVID-19 Caused Delay in Cancer Screenings and Diagnosis

COVID-19 Caused Delay in Cancer Screenings and Diagnosis
(Dreamstime)

By    |   Thursday, 15 October 2020 10:34 AM

COVID-19 caused thousands of critical cancer screenings and biopsies to be deferred out of people’s fear of catching the virus and the shutdown of much of our healthcare system due to the pandemic. This has led to a dangerous delay in the diagnosis and treatment of cancer, according to medical data.

According to The Wall Street Journal, putting cancer care on the back burner could result in over 10,000 deaths from breast and colon cancer alone over the next 10 years. Nearly 17 million people in the U.S. are living with cancer and the coronavirus has affected their care and treatment as well as their health. Patients having radiation or chemotherapy have lowered immune systems and must avoid infections so that they are not battling two potentially deadly diseases.

According to TIME, studies of cancer patients who become infected with the coronavirus found that the death rate of cancer patients from COVID-19 is 28% higher than those without cancer. Experts also fear that the pandemic could impact cancer death rates in the future as many people skip or delay their treatments, while others are too terrified to see their doctors for routine tests for early detection.

According to an article published in Science,  the author, Dr. Norman Sharpless, director of the National Cancer Institute (NCI), said “fear of contracting the coronavirus in health care settings has dissuaded people from screening, diagnosis, and treatment for non-COVID-19 diseases. The consequences for cancer outcomes, for example, could be substantial.”

According to the Journal, deaths from all medical conditions increased this year and experts say the stress from COVID-19, along with deferred medical care, are probable causes. Data from Quest Laboratories shows that newly detected cases of cancer dropped 52% in March and April compared to pre-pandemic figures.

Harvey Kaufman, medical director at Quest, told the Journal that the missing numbers pointed to undiagnosed cases and warned, “Cancer doesn’t take a cause.”

Experts said that biopsies for breast, lung, and colon cancer also plummeted up to 79% between March and July along with new-patient oncology visits.

“Ignoring life-threatening non-COVID-19 conditions such as cancer for too long may turn one public health crisis into many others,” Sharpless said in Science. “Let’s avoid that outcome.”

© 2020 NewsmaxHealth. All rights reserved.


   
1Like our page
2Share
Headline
COVID-19 caused thousands of critical cancer screenings and biopsies to be deferred out of people's fear of catching the virus and the shutdown of much of our healthcare system due to the pandemic. This has led to a dangerous delay in the diagnosis and treatment of cancer,...
coronavirus, cancer, screening, diagnosis
372
2020-34-15
Thursday, 15 October 2020 10:34 AM
Newsmax Media, Inc.
 
Newsmax TV Live

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved